Stephen Yoo – CEO & CSO, STCube Pharmaceuticals

Stephen Yoo highlights the pioneering work that STCube Pharmaceuticals – a US subsidiary of Korean firm STCube – is undertaking in the immuno-oncology field, its three technology platforms, partnership approach, and his outlook for the company’s future.  
Immuno-oncology has revolutionized cancer therapy, but despite the huge success there has been in the area, there are still many unmet patient needs
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report